Skip links

Beyond Skin Deep – Empowering Your Success

By combining carefully selected ingredients such as bioactive peptides, antioxidants, and skin-supporting nutrients, DermBion® offers a holistic approach to inner beauty. Designed for oral intake, its bioavailable formulation works from within to help maintain healthy-looking skin, support the skin’s natural barrier, and promote a radiant, nourished complexion.

Our Service: Empowering Your Success

From raw materials to tailored solutions, we provide end-to-end services to meet your unique needs.

Interested in raw material?

Interested in raw material?

Find Out More
Need a contract manufacturing service?

Need a contract manufacturing service?

Find Out More
Interested in distributorship?

Interested in distributorship?

Find Out More
FREE Consultation with our Sr. Nutritionist

FREE Consultation with our Sr. Nutritionist

Find Out More

Why My Myracle

A New Standard in Wellness

Built on over two decades of research and innovation, our 5G Biotic® products are scientifically validated for efficacy and safety. With over 100 published papers, we prioritize evidence-based solutions to give our clients confidence in products that truly make a difference.

Innovative Fermentation Technology

Products offer unparalleled benefits due to a revolutionary fermentation technology. As the first to globally manufacture a non-heat-killed 5G Biotic®, this process avoids heat degradation to preserve the integrity and potency of the product.

Global Quality and Compliance

With products made in GMP-certified facilities and a commitment to compliant labelling, ethical sourcing, and Halal certification, we are trusted globally for quality and scientific integrity. We offer solutions for diverse markets, from cosmetics to food and beverage.

Two International Patents

Patent 1: Probiotic Composition for Nutraceutical Products (MY-162183-A) It is tailored for nutraceutical products, enhancing their health-promoting potential.
Patent 2: Tumour Cytotoxic Agent and Methods Thereof (MY-158393-A) It focuses on a novel tumour cytotoxic agent and its application methods, showcasing our leadership in cancer treatment research.

Send a Message

Whether you have enquiries or questions, we’re happy to hear from you.

Contact Us
What is your enquiry about?